Does ELTROMBOPAG OLAMINE Cause Disease recurrence? 130 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Disease recurrence have been filed in association with ELTROMBOPAG OLAMINE (ELTROMBOPAG). This represents 0.8% of all adverse event reports for ELTROMBOPAG OLAMINE.
130
Reports of Disease recurrence with ELTROMBOPAG OLAMINE
0.8%
of all ELTROMBOPAG OLAMINE reports
5
Deaths
87
Hospitalizations
How Dangerous Is Disease recurrence From ELTROMBOPAG OLAMINE?
Of the 130 reports, 5 (3.8%) resulted in death, 87 (66.9%) required hospitalization, and 37 (28.5%) were considered life-threatening.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG OLAMINE. However, 130 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG OLAMINE Cause?
Platelet count decreased (3,419)
Death (2,797)
Drug ineffective (1,117)
Platelet count increased (980)
Fatigue (868)
Headache (750)
Nausea (584)
Diarrhoea (558)
Product use in unapproved indication (545)
Malaise (516)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which ELTROMBOPAG OLAMINE Alternatives Have Lower Disease recurrence Risk?
ELTROMBOPAG OLAMINE vs ELUXADOLINE
ELTROMBOPAG OLAMINE vs ELVITEGRAVIR
ELTROMBOPAG OLAMINE vs EMAPALUMAB
ELTROMBOPAG OLAMINE vs EMAPALUMAB-LZSG
ELTROMBOPAG OLAMINE vs EMEND